acetyl l carnitine and depakote L‐carnitine for valproic acid‐induced toxicity Acetyl-L-Carnitine (500 mg)
Description
Acute Leukemias XVI - Biology and Treatment Strategies, 2017

mRNA-4157 (V940) is an mRNA-based personalized neoantigen therapy by encoding up to 34 tumor-specific antigens in a lipid nanoparticle formulation and tailored specifically for cancer patients, subsequently stimulating the immune system to produce reactive T cells targeting patient-specific tumor neoantigens, thereby achieving the goal of controlling and treating tumors

Condition-specific models were generated for each condition (4 h chloroquine-treated, 24 h chloroquine-treated, and untreated) using varying growth thresholds (3080%)

& Aldebasi, Y
